Human testing on beta thalassemia patients: CRISPR readied for … – Genetic Literacy Project
Genetic Literacy Project |
Human testing on beta thalassemia patients: CRISPR readied for …
Genetic Literacy Project esearchers demonstrated how a gene editing technique, known as Crispr-Cas9, could be used to edit living human cells, raising the possibility that a person’s DNA could be altered much as text is changed by a word-processor. Now, two biotech companies … The next generation of CRISPR-Cas9 begins | The StudentThe Student Potential Sickle Cell Disease Treatment Seen in Use of Gene …Sickle Cell Anemia News The future is now: Editing DNA to treat diseaseKSL.com PLoS Blogs (blog) –Now. Powered by Northrop Grumman. (blog) all 8 news articles » |
גלובס |
Hitachi Chemical licenses stem cell tech from Israel’s Accellta
גלובס Hitachi Chemical announced its entry into the contracted cell manufacturing market for regenerative medicine in March 2016. In May 2017, Hitachi Chemical completed its acquisition of the US-based company now named Hitachi Chemical Advanced Therapeutics … |
